A comprehensive view of vaccination/immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

J&J’s Janssen unit stops development of HPV, hepatitis B vaccines with Bavarian Nordic but keeps Ebola and HIV vaccine programs; J&J to focus on hepatitis B treatments currently under development, including two combination therapies in Phase 2 studies
Published: May 11, 2022 by FierceBiotech
US House of Representatives committee reports Emergent destroyed nearly 400 million doses of COVID-19 vaccines due to manufacturing setbacks after multiple warnings that manufacturing processes could cause contamination; Emergent disputes claims
Published: May 11, 2022 by FiercePharma
Novavax swings to Q1 net profit of US$203.0M from net loss of US$223.0M a year ago, with revenue up at US$704.0M from US$447.0M a year ago; company reports US$586.0M in COVID-19 vaccine sales, US$19.0M in royalties, US$99.9M in grant revenue
Published: May 11, 2022 by SeeNews Pharmaceuticals
NIH launches early-stage clinical trial of Epstein-Barr virus vaccine; 125,000 cases of infectious mononucleosis occur annually in US, with 1% of EBV-infected people developing severe complications including hepatitis, neurologic problems, blood issues
Published: May 10, 2022 by States News Service
COVID-19 vaccine makers prepare for smaller booster vaccine market as demand for first shots falls; global booster shot market, including people over 50, adults with health risk factors or who work in high-risk occupations, estimated at 1.7 billion people
Published: May 10, 2022 by CE Noticias Financieras

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count